tetano
Editor, Senior Moderator
Ann Intensive Care. 2020 Apr 20;10(1):45. doi: 10.1186/s13613-020-00661-z.
Therapeutic strategies for critically ill patients with COVID-19.
Li L[SUP]1[/SUP], Li R[SUP]1[/SUP], Wu Z[SUP]2[/SUP], Yang X[SUP]3[/SUP], Zhao M[SUP]4[/SUP], Liu J[SUP]5[/SUP], Chen D[SUP]6,[/SUP][SUP]7[/SUP].
Author information
Abstract
Since the 2019 novel coronavirus disease (COVID-19) outbreak originated from Wuhan, Hubei Province, China, at the end of 2019, it has become a clinical threat to the general population worldwide. Among people infected with the novel coronavirus (2019-nCoV), the intensive management of the critically ill patients in intensive care unit (ICU) needs substantial medical resource. In the present article, we have summarized the promising drugs, adjunctive agents, respiratory supportive strategies, as well as circulation management, multiple organ function monitoring and appropriate nutritional strategies for the treatment of COVID-19 in the ICU based on the previous experience of treating other viral infections and influenza. These treatments are referable before the vaccine and specific drugs are available for COVID-19.
KEYWORDS:
2019-nCoV; Adjunctive intervention; Antiviral therapy; Coronavirus; Respiratory support
PMID:32307593DOI:10.1186/s13613-020-00661-z
Therapeutic strategies for critically ill patients with COVID-19.
Li L[SUP]1[/SUP], Li R[SUP]1[/SUP], Wu Z[SUP]2[/SUP], Yang X[SUP]3[/SUP], Zhao M[SUP]4[/SUP], Liu J[SUP]5[/SUP], Chen D[SUP]6,[/SUP][SUP]7[/SUP].
Author information
Abstract
Since the 2019 novel coronavirus disease (COVID-19) outbreak originated from Wuhan, Hubei Province, China, at the end of 2019, it has become a clinical threat to the general population worldwide. Among people infected with the novel coronavirus (2019-nCoV), the intensive management of the critically ill patients in intensive care unit (ICU) needs substantial medical resource. In the present article, we have summarized the promising drugs, adjunctive agents, respiratory supportive strategies, as well as circulation management, multiple organ function monitoring and appropriate nutritional strategies for the treatment of COVID-19 in the ICU based on the previous experience of treating other viral infections and influenza. These treatments are referable before the vaccine and specific drugs are available for COVID-19.
KEYWORDS:
2019-nCoV; Adjunctive intervention; Antiviral therapy; Coronavirus; Respiratory support
PMID:32307593DOI:10.1186/s13613-020-00661-z